BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30774370)

  • 21. Long Noncoding RNA HIF1A-AS2 Promotes Non-Small Cell Lung Cancer Progression by the miR-153-5p/S100A14 Axis.
    Zhang W; Liu K; Pei Y; Tan J; Ma J; Zhao J
    Onco Targets Ther; 2020; 13():8715-8722. PubMed ID: 32922043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway.
    Sun S; Ma J; Xie P; Wu Z; Tian X
    J Gene Med; 2020 Oct; 22(10):e3230. PubMed ID: 32436353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression.
    Chen Z; Wang F; Xiong Y; Wang N; Gu Y; Qiu X
    Cancer Cell Int; 2020; 20():400. PubMed ID: 32831653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer.
    Xu F; Hu Y; Gao J; Wang J; Xie Y; Sun F; Wang L; Miyamoto A; Xia O; Zhang C
    Curr Cancer Drug Targets; 2023; 23(5):363-378. PubMed ID: 36579395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA HIF1A-AS2 facilitates adipose-derived stem cells (ASCs) osteogenic differentiation through miR-665/IL6 axis via PI3K/Akt signaling pathway.
    Wu R; Ruan J; Sun Y; Liu M; Sha Z; Fan C; Wu Q
    Stem Cell Res Ther; 2018 Dec; 9(1):348. PubMed ID: 30545407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
    Zuo Y; Qu C; Tian Y; Wen Y; Xia S; Ma M
    Biofactors; 2021 May; 47(3):444-460. PubMed ID: 34003544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lncRNAHIF1A-AS2 Promotes Renal Carcinoma Cell Proliferation and Migration via miR-130a-5p/ERBB2 Pathway.
    Zhu Y; Yang Z; Chen H; Pan Y; Gong L; Chen F; Jin X; Wen S; Li Y; Chen G
    Onco Targets Ther; 2020; 13():9807-9820. PubMed ID: 33061459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA HIF1A-AS2 modulates the proliferation, migration, and phenotypic switch of aortic smooth muscle cells in aortic dissection via sponging microRNA-33b.
    Zhang K; Qi Y; Wang M; Chen Q
    Bioengineered; 2022 Mar; 13(3):6383-6395. PubMed ID: 35212609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. circ0005027 Acting as a ceRNA Affects the Malignant Biological Behavior of Hypopharyngeal Squamous Cell Carcinoma by Modulating miR-548c-3p/CDH1 Axis.
    Yang X; Feng C; Jiang D; Xu X; Zhang Y; Wang J; He X
    Biochem Genet; 2023 Nov; ():. PubMed ID: 38019338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
    Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
    Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circle RNA circABCB10 Modulates PFN2 to Promote Breast Cancer Progression, as Well as Aggravate Radioresistance Through Facilitating Glycolytic Metabolism Via miR-223-3p.
    Zhao Y; Zhong R; Deng C; Zhou Z
    Cancer Biother Radiopharm; 2021 Aug; 36(6):477-490. PubMed ID: 32522014
    [No Abstract]   [Full Text] [Related]  

  • 33. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia.
    Hu M; Fu Q; Jing C; Zhang X; Qin T; Pan Y
    Biomed Pharmacother; 2020 May; 125():109703. PubMed ID: 32062551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.
    Yousefi A; Sotoodehnejadnematalahi F; Nafissi N; Zeinali S; Azizi M
    Sci Rep; 2024 Mar; 14(1):5845. PubMed ID: 38462658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA CTBP1-AS2 Facilitates Gastric Cancer Progression via Regulating the miR-139-3p/MMP11 Axis.
    Yang Y; Gao M; Li Y; Li M; Ma Q
    Onco Targets Ther; 2020; 13():11537-11547. PubMed ID: 33204108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA LSINCT5 inactivates Wnt/β-catenin pathway to regulate MCF-7 cell proliferation and motility through targeting the miR-30a.
    Zhang G; Song W
    Ann Transl Med; 2020 Dec; 8(24):1635. PubMed ID: 33490147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
    Li Z; Tang X; Duan S
    Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.